If you and your doctor decide that SECUADO® is right for you, it’s very important to keep wearing it as your doctor has instructed. Remember to change the patch once a day, and don’t use the same application site 2 days in a row. Continue using your SECUADO® patch daily as prescribed.
Let your support team know when you start on the SECUADO® transdermal patch
If you or your support partners – your caregiver, friends, case manager, or health provider – notice any unusual or sudden side effects or changes in symptoms, tell your doctor. Remember, you are not alone. Your personal support team wants to help you find the treatment that is right for you.
Find out if you’re eligible for the SECUADO® Co-Pay Program
Please opt in first
Commercially insured patients with coverage may pay as little as $15 per prescription for up to 12 prescriptions
This offer is valid for commercially insured patients only. It is not valid for prescriptions covered by or submitted for reimbursement in whole or in part under any state or federal healthcare programs (such as Medicaid, Medicare, DOD, VA, or TRICARE) or any state medical pharmacy assistance program.
This offer is valid only for citizens or legal residents of the 50 US states, the District of Columbia, and Puerto Rico.
Patients must have co-pay obligations for SECUADO®. Patients without co-pay obligations for SECUADO®, or whose private commercial insurance has prohibited coupons or co-payment assistance for SECUADO®, are not eligible.
Patients may pay as little as $15 per prescription for up to 12 prescriptions. Co-pay assistance is limited to a maximum amount of $1,200 per month for the first 2 months of eligibility and $600 per month for the remainder of the Enrollment Period.
To enroll in the SECUADO® Co-Pay Program, please complete this Patient Attestation
You must complete this Patient Attestation to receive the SECUADO® Co-Pay Program card:
*Please check all boxes.
You are now leaving the SECUADO® (asenapine) transdermal system website and moving to an external website independently operated and not managed by Noven